Jenny Agnes Greig is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of gene therapy, particularly through her innovative approaches to therapeutic delivery systems. Her work focuses on enhancing the safety and efficacy of gene therapy treatments.

Latest Patents

Jenny Agnes Greig holds a patent for a "Pharmacologically Induced Transgene Ablation System." This invention relates to gene therapy systems designed for the delivery of therapeutic products using replication-defective virus compositions. These compositions are engineered with a built-in safety mechanism that allows for the ablation of the therapeutic gene product, either permanently or temporarily, in response to a pharmacological agent, preferably an oral formulation such as a pill. The invention is based on an integrated approach known as 'PITA' (Pharmacologically Induced Transgene Ablation), which enables the reversible or irreversible regulation of transgene expression.

Career Highlights

Greig's career is marked by her dedication to advancing gene therapy technologies. Her innovative work has the potential to transform treatment options for various genetic disorders. She is affiliated with the University of Pennsylvania, where she continues to contribute to research and development in this critical area of medicine.

Collaborations

Throughout her career, Jenny has collaborated with notable colleagues, including James M. Wilson and Anna P. Tretiakova. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Jenny Agnes Greig is a trailblazer in the field of gene therapy, with her innovative patent showcasing her commitment to improving therapeutic delivery systems. Her work at the University of Pennsylvania and collaborations with esteemed colleagues highlight her significant contributions to medical science.